AJPHR

American Journal Of Pharmacy And Health Research

ISSN NO.: 2321-3647
October 2025 Issue 10
1

Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction

Dr. Namitha Rachel Biji 1, Prof. Dr. S.K Mathew2, Dr. Dhanu Josey 3, Dr. Joseph John 4

1 Pharm D Intern, Nazareth College Of Pharmacy, Thiruvalla, Kerala

2 Guide and Professor, Department of General Medicine, Believers Church Medical College Hospital, Thiruvalla, Kerala

3 Clinical Pharmacist, Department of General Medicine, Believers Church Medical College Hospital, Thiruvalla, Kerala

4 Assistant Professor, Department Of General Medicine, Believers Church Medical College Hospital, Thiruvalla, Kerala.

ABSTRACT

Dapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin.

Keyword: SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.